---
title: Regular Swimming, Vascular Function, and Arthritis
nct_id: NCT01836380
overall_status: COMPLETED
phase: NA
sponsor: University of Texas at Austin
study_type: INTERVENTIONAL
primary_condition: Osteoarthritis
countries: United States
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT01836380.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT01836380"
ct_last_update_post_date: 2015-03-26
last_seen_at: "2026-05-12T06:12:33.085Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Regular Swimming, Vascular Function, and Arthritis

**Official Title:** Effects of Swimming Exercise and Cycling Exercise Interventions on Vascular Function, Inflammation and Pain in Middle-aged and Older Adults With Osteoarthritis.

**NCT ID:** [NCT01836380](https://clinicaltrials.gov/study/NCT01836380)

## Key Facts

- **Status:** COMPLETED
- **Phase:** NA
- **Study Type:** INTERVENTIONAL
- **Target Enrollment:** 48
- **Lead Sponsor:** University of Texas at Austin
- **Conditions:** Osteoarthritis
- **Start Date:** 2013-01
- **Completion Date:** 2014-12
- **CT.gov Last Update:** 2015-03-26

## Brief Summary

Hypothesis #1: The investigators hypothesize that both swimming training and cycling training will demonstrate significant improvements in endothelium-mediated vasodilation and central artery compliance in this population and that there will be no difference in the magnitude of increases between the water-based and land-based exercise interventions.

Hypothesis #2: The investigators hypothesize that the improvements in endothelium-dependent vasodilation and arterial compliance in response to exercise training interventions will be related to the corresponding reductions in inflammatory biomarkers.

Hypothesis #3: The investigators hypothesize that both swimming exercise and cycling exercise will improve functional capacities and disease progression in middle-aged and older adults with osteoarthritis.

## Detailed Description

Middle-aged and older men and women (40-90 years old) of all races and ethnic backgrounds will serve as subjects after obtaining their written, informed consent. All the subjects will have a radiological diagnosis of osteoarthritis according to American College of Rheumatology criteria.

## Eligibility

- **Minimum age:** 40 Years
- **Maximum age:** 90 Years
- **Sex:** ALL
- **Healthy Volunteers:** No

```
Inclusion Criteria:

* All the subjects will have a radiological diagnosis of osteoarthritis according to American College of Rheumatology criteria
* Subjects will be sedentary (i.e., no regular physical activity for at least the prior 1 year)

Exclusion Criteria:

* Subjects with significant intima thickening,
* plaque formation, and/or characteristics of atherosclerosis.
* unstable cardiac or pulmonary diseases.
* joint replacement surgery in the previous year.
* intraarticular injection nor systemic steroids within previous 3 months.
* severe disabling co-morbidity that disallows receiving exercise therapy.
* excess alcohol use (\>21 drinks/week).
* unwillingness to perform exercise.
* fear of water.
* mental incapability
```

## Arms

- **Swimming Training** (EXPERIMENTAL) — The swimming training will be performed at two swimming pools on the campus of The University of Texas at Austin (University Aquatic Center or Gregory Gym pool). In the first 2-3 weeks a swimming instructor will provide personalized skill feedback to the subjects in the swim training group. Subjects will swim 15-20 minutes/day at a relatively low intensity of exercise while they receive swimming skill instructions. As their overall level of fitness and exercise skill improve, the intensity and duration of exercise will increase to 40-45 minutes/day at a moderate intensity of 70-75% of maximal heart rate. Exercise training will be performed three days per week.
- **Cycling Training** (EXPERIMENTAL) — The cycling training will be conducted in the newly-constructed Exercise Training Intervention Core-Laboratory in the Department of Kinesiology and Health Education on the University of Texas campus. In the first 2-3 weeks a cycling instructor will provide personalized skill feedback to the subjects in the cycle training group. Subjects will cycle 15-20 minutes/day at a relatively low intensity of exercise while they receive cycling skill instructions. As their overall level of fitness and exercise skill improve, the intensity and duration of exercise will increase to 40-45 minutes/day at a moderate intensity of 70-75% of maximal heart rate. Exercise training will be performed three days per week.

## Interventions

- **Exercise Training** (BEHAVIORAL)

## Primary Outcomes

- **Central Arterial Compliance** _(time frame: three months)_ — Central Arterial Compliance: Common carotid artery diameter will be measured from the images derived from an ultrasound machine (Philips HDI-5000, Bothel, WA) equipped with a high-resolution linear-array transducer as previously described. A longitudinal image of the cephalic portion of the common carotid artery will be acquired 1-2 cm proximal to the carotid bulb with the transducer placed at 90 degrees to the vessel. The images will be analyzed with Vascular Tools 5 image analyses software. Similarly, intima-media thickness will be measured at end diastole as previously described. The combination of ultrasound imaging of a common carotid artery with simultaneous tonometric-obtained arterial pressure waveforms from the contralateral artery permits noninvasive determination of carotid artery compliance. Arterial compliance is a function of the increase in arterial pressure and a corresponding increase in cross-sectional area.
- **Inflammatory Markers** _(time frame: three months)_ — Fasted state, venous blood samples will be obtained to assess biological markers of inflammation. Serum C-reactive protein (CRP) will be assayed using ELISA (Alpha Diagnostics; San Antonio, TX). Inflammatory cytokines including Interleukin-6 (IL-6), TNF-α, and soluble receptor 1 (sTNFR1) will be analyzed from serum samples using a multiplex assay system (Bioplex, BioRad; Hercules, CA)
- **Flow-Mediated Dilatation** _(time frame: three months)_ — Flow-Mediated Dilatation is a non-invasive method to assess vascular endothelial function as previously described. Brachial artery diameters and blood flow velocity will be measured from images derived from a Doppler ultrasound machine equipped with a high-resolution linear array transducer. A longitudinal image of the brachial artery will be acquired 5-10 cm proximal to the antecubital fossa. A blood pressure cuff will be placed on the forearm 3-5 cm distal to the antecubital fossa. The cuff will be inflated to 100 mmHg above resting systolic blood pressure for 5 minutes. After cuff deflation, ultrasound-derived measurements of the brachial artery diameters and blood velocity will be taken for 3 minutes. FMD will be calculated as a percent increase in brachial artery diameter at the post-blood flow occlusion compared with the pre-blood flow occlusion.

## Secondary Outcomes

- **Mobility** _(time frame: three month)_
- **Muscular Strength** _(time frame: three months)_
- **Body Mass and Composition** _(time frame: three months)_
- **Self-Reported Physical Function and Pain** _(time frame: three months)_
- **Health-Related Quality of Life** _(time frame: three months)_

## Locations (1)

- The University of Texas at Austin, Austin, Texas, United States

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.phases` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.maxAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `outcomes.secondary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.the university of texas at austin|austin|texas|united states` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT01836380.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT01836380*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*